Position in BIIB
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$563,700
+$171,374 QoQ
Shares Held
2,609
+21.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#556
of 1,031 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Parcion Private Wealth LLC holds $27,146,345 across 9 Drug Manufacturers - General names. BIIB ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
28,497 | $10,319,333 | |
| 2 | MRK |
Merck & Co., Inc.
|
30,676 | $3,941,865 | |
| 3 | ABBV |
AbbVie Inc.
|
15,052 | $3,787,684 | |
| 4 | LLY |
ELI LILLY & Co
|
2,856 | $3,425,571 | |
| 5 | JNJ |
Johnson & Johnson
|
10,739 | $2,727,382 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
28,719 | $1,654,788 | |
| 7 | BIIB |
Biogen Inc.
This page
|
2,609 | $563,700 | |
| 8 | PFE |
Pfizer Inc
|
21,037 | $506,570 |
All Filings in BIIB
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $563,700 | 2,609 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $392,326 | 2,140 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $368,875 | 2,096 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $226,789 | 1,619 | Shares | Sole | 2025-10-14 | |
| 2025-03-31 | $235,912 | 1,724 | Shares | Sole | 2025-05-02 | |
| No filing history on record for this holder in this stock. | ||||||